Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Random Thoughts


...great traders know how to take a loss.

  • The other side of the "erosion of the middle class" trade.

  • I mentioned earlier that my stochastics are "middle of the road." That's not a blanket statement--the stochastics in the BKX are pretty toppy, which fits nicely with the Citigroup resistance at $48.

  • If you haven't read Jeff Saut's weekly missive, you're missing some excellent insight. He remains, in my view, as good as it gets.

  • Google is toying with it's 200-day again ($347ish). Keep that massive gap (below) on your radar as well, as a trade through $332 "works" to $300ish.

  • Keep an eye on that triple top in Pan American Silver ($25.50ish). Ditto Silver Standard (SSRI) as it tickles $19.

  • Does this mean I should feel guilty for letting MVHQ watch March Madness?

  • Note big pharma as the DRG tickles 335 and respect the acne in the context of extended stochastics.

  • My first job real job was flipping bagels in Great Neck, NY. I was 13 years old and worked with Rob Camilletti of Cher fame.

  • Also eye Citigroup as it gives up the early nub with a wary eye cast towards $48.

  • If you miss the Grateful Dead, don't miss Ratdog. I'll be there at the Beacon, happy as a clam.

  • Billionaire investor Warren Buffett on Monday reiterated his long-standing prediction that the U.S. dollar would weaken over time, Reuters reported. "I think over time the dollar is going to weaken. I have no idea whether it will be this year or five years from now," he told television network CNBC.

  • Good traders know how to make money but great traders know how to take a loss. Setting stops is the first step towards great trading.

  • NYSE breadth is steadily slipping (3:2 negative) as the post-expiration hangover starts to subside.

  • I've been "trading around" energy, metals and pharma on the long side while dabblin' with the financials and tech (ex-SunMicro) on the short side.

  • I'm finding it increasingly difficult to digest the one-sided rhetoric championing the economic expansion (without mentioning the attendant cost). Or maybe I'm just cranky due to this naggin' chest cold?

  • I continue to think that this Ambien situation is gonna wake up and bite Sanofi Aventis in the arse.

position in ssri, sunw

Todd Harrison is the founder and Chief Executive Officer of Minyanville. Prior to his current role, Mr. Harrison was President and head trader at a $400 million dollar New York-based hedge fund. Todd welcomes your comments and/or feedback at

The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.

Featured Videos